Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia

L. Mellibovsky, A. Diez, J. Aubia, X. Nogues, E. Perez-Vila, S. Serrano, Robert R. Recker

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

This report describes a case of chronic myelomonocytic leukaemia (CMML) in whom a complete remission was achieved and sustained 15 months after treatment with 25-OH vitamin D3. No side-effects were observed. Although vitamin D3 has been used in the treatment of myelodysplastic syndromes, to our knowledge this is the first case of longstanding remission in a patient with CMML. This 'differentiation therapy' might be considered as a possible alternative in the management of this disease.

Original languageEnglish
Pages (from-to)811-812
Number of pages2
JournalBritish Journal of Haematology
Volume85
Issue number4
Publication statusPublished - 1993

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Mellibovsky, L., Diez, A., Aubia, J., Nogues, X., Perez-Vila, E., Serrano, S., & Recker, R. R. (1993). Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia. British Journal of Haematology, 85(4), 811-812.